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Background: Peroxiredoxin IV metabolizes endoplasmic reticulum-derived hydrogen peroxide.
Results: In contrast to other peroxiredoxins, peroxiredoxin IV is insensitive to hyperoxidation within its cellular environment.
Conclusion: There is a lack of a robust peroxiredoxin IV recycling system within the endoplasmic reticulum.
Significance: Studying the reduction of peroxiredoxin IV highlights the different mechanisms for maintaining redox status
within different cellular compartments.
Typical 2-Cys peroxiredoxins are required to remove hydro-
gen peroxide from several different cellular compartments.
Their activity can be regulated by hyperoxidation and conse-
quent inactivation of the active-site peroxidatic cysteine. Here
we developed a simple assay to quantify the hyperoxidation of
peroxiredoxins. Hyperoxidation of peroxiredoxins can only
occur efficiently in the presence of a recycling system, usually
involving thioredoxin and thioredoxin reductase. We demon-
strate that there is a marked difference in the sensitivity of the
endoplasmic reticulum-localized peroxiredoxin to hyperoxida-
tion compared with either the cytosolic or mitochondrial
enzymes. Each enzyme is equally sensitive to hyperoxidation
in the presence of a robust recycling system. Our results dem-
onstrate that peroxiredoxin IV recycling in the endoplasmic
reticulum is much less efficient than in the cytosol or mito-
chondria, leading to the protection of peroxiredoxin IV from
hyperoxidation.
Peroxiredoxin (Prxs)2 are a family of ubiquitous, highly
expressed antioxidant enzymes capable of efficiently metabo-
lizing hydrogen peroxide (H2O2) (1). They are the dominant
cellular peroxide-reducing enzymes on the basis of their rela-
tive reactivity and protein concentration (2). In human cells,
there are six Prxs that differ in subcellular localization and
number of catalytic cysteine residues (3). The typical 2-Cys Prxs
are localized to the cytosol (PrxI and II), the mitochondrion
(PrxIII), and the endoplasmic reticulum (ER) (PrxIV). Under
normal conditions, the active-site peroxidatic cysteine rapidly
cycles between a sulfenic acid, disulfide, and free thiol, with the
reduction of the disulfide being catalyzed by a member of the
thioredoxin family of enzymes (3) (Fig. 1). The reactivity of the
peroxidatic cysteine toward H2O2 is dependent upon its pres-
ence in the folded active site (4). Upon sulfenylation, there is a
local unfolding of the active site to allow the peroxidatic cys-
teine to form a disulfide with a resolving cysteine located out-
side of the active site. Crucially, this localized unfolding reduces
the reactivity of the peroxidatic cysteine because it is no longer
in the optimal environment for reaction with H2O2. When the
disulfide has been reduced, the active site refolds to allow reac-
tion with the next H2O2 molecule. In the presence of high con-
centrations of H2O2, the peroxidatic cysteine can become
hyperoxidized to form cysteine sulfinic acid, a modification
that renders the protein inactive. Hyperoxidation occurs in
competition with disulfide formation and can, therefore, occur
more efficiently at high H2O2- concentrations. Although recy-
cling is not essential for hyperoxidation (5), at lower H2O2 con-
centrations, disulfide formation occursmore efficiently, requir-
ing recycling to allow hyperoxidation to occur (6, 7). This
recycling is usually catalyzed by a thioredoxin domain-contain-
ing protein. It has also been shown that the hyperoxidized, sul-
finylated active-site cysteine can be recycled back to the thiol
and, thereby, reactivated by sulfiredoxin, an ATP-dependent
enzyme localized to the cytosol (8). The inactivation of Prxs by
hyperoxidation of the active-site cysteine residue has led to the
suggestion that this modification provides a mechanism to
allow H2O2 to act as a signaling molecule (3).
PrxIV reducesH2O2 produced by the ER oxidase 1 (Ero1) (9).
The oxidized PrxIV formed can pass the disulfide bond to a
member of the protein disulfide isomerase (PDI) family (10, 11).
Therefore, during reduction of one molecule of oxygen to two
molecules of water, two disulfide bonds can be introduced to
PDI family members by Ero1 and PrxIV. The crystal structure
of PrxIV shows that it forms a stable decamer and shares the
same active sites as PrxI-III (4). Also like other Prxs, the reac-
tivity of PrxIV toward H2O2 is high (12), making PrxIV the
likely primary target of H2O2. Under conditions where Ero1 is
activated, such as following treatment of cells with DTT, PrxIV
can become hyperoxidized (9), although the physiological rele-
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vance of this modification is uncertain. In addition, it is
unknown whether the ER contains a sulfiredoxin capable of
recycling any sulfinylated PrxIV.
We developed a simple assay on the basis of one-dimensional
isoelectric focusing (IEF) that allows us to monitor the hyper-
oxidation of all intracellular Prxs simultaneously. The ability to
quantify the oxidation status of the Prxs enabled us to monitor
the sensitivity of the Prxs to hyperoxidation within distinct cel-
lular compartments. Here we show that ER-localized PrxIV is
insensitive to hyperoxidation even at concentrations of H2O2
that cause hyperoxidation of Prxs localized to the cytosol and
mitochondria. In addition, we could not find any evidence for
the existence of an ER-localized sulfiredoxin.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—An antibody was raised in rabbits
to a peptide with the sequence of the first 11 N-terminal amino
acids of mature PrxIV (WETEERPRTRC). The commercial
rabbit polyclonal antibodies used were anti-Prx II and III
(Abcam) and anti-Prx-SO2–3 (AbFrontier). An anti-PrxIV
mouse monoclonal antibody (Abcam) was also used. The fluo-
rescently conjugated anti-mouse and anti-rabbit IgG 680 and
800 secondary antibodies were purchased from either Li-Cor
IRDye or Thermo-Scientific DyeLight. Human recombinant
PrxIV, human PDI, Escherichia coli thioredoxin, and Saccharo-
myces cerevisiae thioredoxin reductase were purified as
described previously (4, 9, 10, 13).
Preparation of Samples for IEF—Cells were maintained in
DMEM supplemented with 10% fetal bovine serum before
being treated with 20 mM N-ethylmaleimide to prevent disul-
fide exchange. Cells were lysed in buffer A (50 mM Tris-HCl
buffer (pH 8.0) containing 150 mM NaCl, 5 mM EDTA, and 1%
(w/v) Triton X-100). Cell lysates were centrifuged (10,000  g
for 10 min at 4 °C) to remove insoluble material, and 5 volumes
of ice-cold acetone were added to the supernatant and incu-
bated for at least 2 h at 20 °C. The protein precipitated was
isolated by centrifugation (10,000  g for 10 min at 4 °C) and
washed with 80% ice-cold acetone. The precipitate was isolated
by centrifugation, and the pellet was air-dried and suspended in
IEF sample buffer consisting of 7 M urea, 2 M thiourea, 2% (w/v)
CHAPS, 0.8% (v/v) ampholytes (pH 4–6), 50mMDTT, 4% (v/v)
glycerol, and 0.02% (w/v) bromphenol blue. The protein was
dissolved in IEF sample buffer for 1 h at room temperature
before application to a one-dimensional IEF gel.
One-dimensional IEF—A 10% gel containing 9 M urea, 0.4%
(v/v) ampholytes mix (pH4–6), and 1% (w/v) CHAPS was cast
and run using the mini-VE system (Amersham Biosciences).
The cathodic buffer was 10mMphosphoric acid, and the anodic
buffer was 25 mM Tris base. One-dimensional IEF was carried
out at 1000 V and 2 mA for 4 h. Focused gels were rinsed in
water and soaked in transfer buffer for 20 min at room
temperature.
Immunoblotting—Following one-dimensional IEF, proteins
were transferred to a nitrocellulose membrane (Li-Cor Biosci-
ences). Nonspecific binding was blocked using 5% (w/v) nonfat
dried skimmed milk in Tween/Tris-buffered saline (TTBS) (50
mMTris buffer (pH 7.5) containing 150mMNaCl and 0.1% (v/v)
Tween 20). Membranes were incubated with primary antibody
for 16 h at 4 °C in TTBS. The secondary antibody was diluted
1:5000 in TTBS, and incubations were performed in a light-
shielded box for 45 min at room temperature. Specific proteins
were visualized using an Odyssey SA imaging system (Li-Cor
Biosciences). For quantification of fluorescent immunoblot
analyses, scans were performed at the minimum intensities
required to see all relevant proteins. Densitometry was then
performed on unmodified output images using ImageJ
(National Institutes of Health) (fraction hyperoxidized 
SO2H/(SH  SO2H)). Statistical analysis was carried out using a
one-tailed, paired t test assuming unequal variance between
samples.
FIGURE 1.Reaction cycle andhyperoxidationof the2-CysPrxs. Schematic depicting the reaction cycle of the 2-Cys family of Prxs. 1, the peroxidatic cysteine
reacts with a H2O2molecule when present in the fully folded active site pocket to become sulfenylated. 2a, the active site unfolds, thereby preventing further
modification of the peroxidatic cysteine. 2b, a second H2O2 molecule can react with the peroxidatic cysteine but only if it reacts before the active site pocket
unfolds. 3, the resolving cysteine reacts with the sulfenylated peroxidatic cysteine to form a disulfide. 4, the disulfide is reduced, and the active site pocket
refolds. The hyperoxidation of the Prxs is dependent upon the rapid reformation of the active site pocket, which requires efficient reduction of the disulfide.
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Metabolic Labeling and Pulse-Chase Analysis—Cells were
starved for 30 min in cysteine/methionine-free DMEM and
then radiolabeled in the same medium containing 22 Ci/ml
EXPRESS35S protein labeling mix (PerkinElmer Life Sciences).
After 30min of incubation at 37 °C, the radiolabelwas removed,
and cells were washed with PBS and incubated in complete
DMEM for various lengths of time. Cells were washedwith PBS
before being lysed in buffer A. Cell debris was removed by cen-
trifugation (10,000  g for 10 min at 4 °C). The lysates were
precleared by adding proteinA-Sepharose (Generon) and incu-
bated for 30min at 4 °C. For immunoisolation, anti-PrxIV anti-
body was added to protein A-Sepharose. Samples were incu-
bated for 16 h at 4 °Cwith end-over-endmixing. The Sepharose
beads were pelleted by centrifugation (600  g for 1 min) and
washed three timeswith bufferA. Proteinswere elutedwith IEF
sample buffer prior to loading onto a one-dimensional IEF gel.
Gelswere fixed, dried, and exposed to a phosphorimaging plate.
Radioactivity was detected using a Fujifilm FLA-7000 Phosphor-
Imager.Quantification of band intensities was carried out using
ImageJ software.
In Vitro Assays—Recombinant human PrxIV (2.8 M) was
expressed and purified as described previously (9) and mixed
with GSH (1 mM), GSH/GSSG (3:1,1 mM), reduced PDI (2.8
M), DTT (1 mM), or a thioredoxin recycling system (2.8 M
thioredoxin, 2.8 M thioredoxin reductase, and 1.5 mM
NADPH) in 50 mM Tris buffer (pH 7.5) containing 150 mM
NaCl and 1 mM EDTA. Various concentrations of H2O2 were
added, and samples were incubated for 10 min at 30 °C. IEF
sample buffer (5 volumes)was added to each sample andmixed
for 1 h before being loaded onto a one-dimensional IEF gel.
An immunoblot analysis using the polyclonal PrxIV anti-
body was carried out, and band intensities were quantified
using ImageJ software.
RESULTS
Quantitative Assay for the Hyperoxidation of Prxs—The
hyperoxidation of the members of the typical 2-Cys family of
Prxs has been detected previously, either by using an antibody
(-SO2) that recognizes the sulfinylated active-site peptide of
all 2-Cys Prxs (14) or by separation of the various oxidation
states of the proteins by two-dimensional gel analysis (15).
Although the antibody approach is very sensitive and provides a
qualitative analysis of hyperoxidation, it suffers from a lack of
specificity toward individual members of the family (9) and is
non-quantitative in that it cannot assess the fraction of the total
peroxiredoxin hyperoxidized. Such quantification can be pro-
vided by a two-dimensional gel analysis, but this approach is
not suitable for screening large numbers of samples (16). To
overcome this problem, we used a one-dimensional IEF
approach that separates the unmodified or sulfenylated forms
from the sulfinylated proteins on the basis of charge. To vali-
date this approach, we treated HT1080 cells with increasing
concentrations of DTT, separated the resulting cell lysates by
one-dimensional IEF, and visualized specific proteins with
either an antibody to PrxIV (-PrxIV) or the -SO2 antibody
(Fig. 2A). We have shown previously that DTT generates H2O2
in the ER by an Ero1-dependentmechanism and leads to hyper-
oxidation of PrxIV (9). Because the antibodies are raised in dif-
ferent species, we could use different fluorescently labeled
secondary antibodies on the same blot to determine the comi-
gration of proteins. As the concentration of DTT increases, so
does the appearance of amore acidic formof PrxIV (Fig. 2A, top
panel) that comigrates with protein recognized by the -SO2
antibody (bottom panel). The additional bands seen with the
-SO2 antibody (center panel) reflect cross-reactivity of this
antibody with other 2-Cys Prxs that show some increased reac-
tivity at high concentrations of DTT (see below). Strikingly, at
higher concentrations of DTT,most of the PrxIVwasmodified.
To demonstrate that PrxIV was being modified following DTT
treatment by the Ero1-dependent production of H2O2, we
repeated the experiment with a cell line that contains low levels
of Ero1 because of stable shRNAknockdown (17).No increase
in hyperoxidized PrxIV was seen, even at high concentrations
FIGURE 2. Assay for Prx hyperoxidation in HT1080 and Ero1-depleted cells. HT1080 cells (A) or Ero1-depleted cells (B) were treated with varying concen-
trations of DTT, as indicated, for 5min at 37 °C. Cells were lysed, and samples were resolved on a one-dimensional IEF gel prepared using pH 4–6 ampholytes.
After one-dimensional IEF, samples were transferred to nitrocellulose, and immunoblots were probed with either a mousemonoclonal (A, top panel, -prxIV),
a rabbit polyclonal antibody to Prx IV (B), or a rabbit polyclonal antibody to sulfinylated Prxs (A, center panel, -SO2). In A, blots were developed with a green
fluorescent anti-mouse IgG antibody (top panel) or a red fluorescent anti-rabbit IgG antibody (center panel). Images are from the same blot, with the bottom
panelbeing anoverlay of the top and center panels, illustrating overlap (yellow). The blot in Bwasdevelopedwith an anti-rabbit secondary antibody. The acidic,
hyperoxidized form of PrxIV (SO2H) is resolved from the unmodified more basic form (SH). Each experiment was carried out three times with similar results.
Protection of Peroxiredoxin IV fromHyperoxidation
5492 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 9•FEBRUARY 28, 2014
 at G
lasgow
 U
niversity Library on June 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
of DTT (Fig. 2B). Hence, the one-dimensional IEF system can
separate unmodified from sulfinylated PrxIV and can be used to
specifically quantify the levels of hyperoxidized PrxIV as well as
other members of the 2-Cys Prx family.
Recycling of Hyperoxidized PrxIV—The modification of the
2-Cys Prxs to the sulfinylated form blocks reactivity of the
active-site peroxidatic cysteine (7). However, a cytosolic
enzyme called sulfiredoxin has been identified that catalyzes
recycling of the sulfinylated peroxidatic cysteine back to an
active thiol (8). To investigate whether hyperoxidized PrxIV
could also be recycled, we first treated cells with a pulse of DTT
to hyperoxidize about 80% of the protein (Fig. 3A), removed the
DTT, and determined the recovery over 24 h. The hyperoxi-
dized fraction dropped to40%, indicating that either the pre-
existing PrxIV was being recycled or that newly synthesized
protein was replacing the hyperoxidized PrxIV. To determine
whether pre-existing hyperoxidized PrxIV was being recycled,
we first radiolabeled newly synthesized protein for 30 min,
treated it withDTT to hyperoxidize the PrxIV, and chased it for
up to 16 h in fresh medium. For this experiment, we used a cell
line overexpressing PrxIV (18) because the endogenous protein
was not radiolabeled efficiently.We immunoisolated the radio-
labeled PrxIV at various time points and separated the oxidized
forms of PrxIV by one-dimensional IEF (Fig. 3B). None of the
hyperoxidized PrxIV radiolabeled during the pulse period was
recycled, suggesting that, for PrxIV, the only mechanism to
regenerate the active enzyme following hyperoxidation is by
new protein synthesis. An immunoblot analysis of the recovery
of PrxIV from hyperoxidation in this overexpressing cell line
gave a similar result as that from HT1080s (Fig. 3C). That this
recovery was due to new protein synthesis was confirmedwhen
we analyzed the recovery of hyperoxidized PrxIV following a
DTT pulse in the presence of the protein synthesis inhibitor
cycloheximide (Fig. 3D). Some recovery was observed after 3 h
in the absence of cycloheximide, but no recoverywas seen in the
presence of the protein synthesis inhibitor. Taken together,
these results strongly suggest that there is no sulfiredoxin activ-
ity to recycle hyperoxidized PrxIV in the ER.
Differential Hyperoxidation of Prxs Located in Different
IntracellularCompartments—The ability to quantify the extent
of hyperoxidation of 2-Cys Prxs enabled us to evaluate the con-
sequence of the addition ofH2O2 toHT1080 cells on the hyper-
oxidation of Prxs localized to the cytosol (PrxII), mitochondria
(PrxIII), or the ER (PrxIV). A marked transition from mostly
unmodified (basic) to mostly hyperoxidized (acidic) PrxII was
seen after the addition of 100 M H2O2 (Fig. 4A). As demon-
strated previously, PrxIII was slightly less sensitive to hyperoxi-
dation, requiring higher concentrations to become hyperoxi-
dized (5, 19). PrxIV was largely resistant to hyperoxidation,
with only low levels of hyperoxidation, even at 10 mM H2O2.
The difference in sensitivity to hyperoxidation between PrxII
and PrxIV was statistically significant (p 0.01 at 0.1 and 1mM
H2O2). Similar differential susceptibility of the Prxs to hyper-
oxidation was also observedwhen the experiment was repeated
with HeLa cells (results not shown). The addition of H2O2
exogenously to cells is unlikely to reflect a physiological
increase in concentration, so to generate a more gradual
increase, we added various concentrations of glucose oxidase to
the cellmedium to generateH2O2 in situ and assayed the extent
of hyperoxidation after 3 h (Fig. 4B). Similar differential hyper-
oxidation of the Prxs in different cellular compartments was
observed, with PrxIV being less sensitive to hyperoxidation
than PrxII or PrxIII (p 0.01 at 33 units/liter and 0.05 at 100
units/liter, comparing PrxII to PrxIV). Taken together, these
results demonstrate that there are distinct sensitivities to
hyperoxidation of the various 2-Cys Prxs in different cellular
compartments, with PrxIV being particularly resistant to exog-
enously added H2O2.
FIGURE 3. Recycling of hyperoxidized PrxIV. HT1080 cells (A and D) or a
stable HT1080 cell line overexpressing PrxIV (B and C) were treated with DTT
(5 mM) for 10 min at 37 °C to induce hyperoxidation of PrxIV. DTT was
removed, cellswere incubated in completeDMEM for the indicated time, and
cell lysates were prepared as described in Fig. 2. A, immunoblot analysis of
HT1080 indicating some recoveryof unmodifiedPrxIV.B, cells overexpressing
PrxIV were radiolabeled for 30 min, followed by treatment with DTT (5 mM).
PrxIV was immunoisolated by using a polyclonal antibody to PrxIV. A control
sample, isolated without antibody, was also processed (-ab). The samples
were separated on a one-dimensional IEF gel, and the dried gel was exposed
to phosphorimaging analysis. C, immunoblot analysis of the PrxIV-overex-
pressing cell line indicating some recovery of unmodified PrxIV. D, immuno-
blot analysis ofHT1080 cells either treatedwith cycloheximide (0.5mM) or not
treated, as indicated. Cells were exposed to cycloheximide after treatment
with DTT (5 mM) for the indicated times. The average of the fraction of PrxIV
hyperoxidized from three independent experimentswas calculated andplot-
ted against time after DTT treatment. Error bars indicate themean S.D. The
statistical significance of the difference between the 3-h chase timewith and
without cycloheximide is as indicated.
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Wehave shown above that PrxIV can become hyperoxidized
by an Ero1-dependent process in the presence of DTT. We
evaluated whether the Ero1-generated H2O2 could also hyper-
oxidize PrxII or PrxIII in HT1080 cells (Fig. 4C). When DTT
was added to cells, PrxIV was mostly hyperoxidized. However,
only modest, but statistically significant (p 0.05), levels of
hyperoxidation of PrxII and PrxIII were observed at higher con-
centrations of DTT. These results indicate that ER-generated
H2O2 can enter the cytosol at a sufficient concentration to
hyperoxidize PrxII. In addition, it is clear that, in the presence of
Ero1-generatedH2O2 and a reducing agent, PrxIVdoes become
sensitive to hyperoxidation.
The differential sensitivity of the 2-Cys Prxs to hyperoxida-
tion by exogenously added H2O2 may be explained if the indi-
vidual Prxs differed in their intrinsic sensitivity to hyperoxida-
tion. It has been demonstrated that the efficiency of reduction
of the disulfide formed between the peroxidatic and the resolv-
ing cysteine of the 2-Cys Prxs has a dramatic effect on the sen-
sitivity to hyperoxidation (6, 7), so variations in the reductive
pathways in each of the cellular compartments could also
account for the variations in sensitivity to hyperoxidation.
Alternatively, the lack of hyperoxidation of PrxII or PrxIII by
ER-generated H2O2 and the resistance of PrxIV to exogenously
generated oxidant could be due to the ER membrane being
impermeable to H2O2.
To assess whether PrxIV is intrinsically insensitive to hyper-
oxidation,we used purified components in an attempt to recon-
stitute a pathway of hyperoxidation. Note that purified recom-
binant PrxIV is primarily oxidized (9), so the disulfide would
need to be reduced to allow oxidation. In the absence of any
FIGURE 4. Differential sensitivity of Prxs located in different intracellular compartments to hyperoxidation. HT1080 cells were exposed to increasing
concentrations of H2O2 (0–10mM) for 10min (A), units of glucose oxidase (0–100 units/l) for 3 h (B), or concentrations of DTT (C). Cell lysates were prepared as
described in Fig. 2 and separated by one-dimensional IEF. Immunoblot analyses were developedwith polyclonal antibodies to PrxII (-prxII), PrxIII (-prxIII), or
PrxIV (-prxIV), as indicated. The fraction of hyperoxidized Prx for the displayed image was calculated and plotted graphically for each treatment. Each
experiment was carried out in triplicate with similar results obtained. Error bars indicate the mean S.D.
Protection of Peroxiredoxin IV fromHyperoxidation
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other components, PrxIVdoes not becomehyperoxidized, even
at 10 mM H2O2 (Fig. 5). However, in the presence of thiore-
doxin, thioredoxin reductase, and NADPH, PrxIV is readily
hyperoxidized at concentrations of H2O2 as low as 100 M.
These results demonstrate that PrxIV will become hyperoxi-
dized at similar concentration of H2O2 that modified PrxII in
cells if a robust recycling system is present. Within the ER, the
initial reductase for PrxIV is likely to be a member of the PDI
family (9). Indeed, when a stoichiometric amount of reduced
PDI was incubated with PrxIV, hyperoxidation occurred. The
sensitivity of PrxIV to hyperoxidation was maximized when
GSH (1mM)was includedwith reduced PDI, conditions that, as
we have shown previously, fully reduce PrxIV (10). The ER
lumen is unlikely to contain such reducing conditions, so the
level of hyperoxidation of PrxIV in cells will most likely reflect
the prevailing ratio of GSH:GSSG. Indeed, in the presence of a
3:1 ratio of GSH:GSSG and reduced PDI, PrxIV was less sensi-
tive to hyperoxidation than with GSH alone (p  0.03). An
absolute requirement for PDI in this system was evidenced by
the lack of PrxIV hyperoxidation when incubated in the pres-
ence of increasing concentrations of H2O2 and GSH at 1 mM.
Analysis of the extent of hyperoxidation of PrxIV confirmed
that, at 10 mM H2O2, statistically significant differences were
seen between the presence and absence of all reductant apart
from GSH alone (p  0.05 (PDI) to p  0.005 (thioredoxin,
thioredoxin reductase, andNADPH).Hence, the level of hyper-
oxidation of PrxIV reflects the efficiency of the recycling system
and requires a member of the PDI family to catalyze the initial
reduction of the active site disulfide.
Cellular PrxIV Becomes Hyperoxidized in the Presence of a
Reducing Pathway—The results with purified protein compo-
nents provide compelling evidence that PrxIV can become
hyperoxidized at quite low concentrations of H2O2. To deter-
mine whether an equivalent sensitivity of the three Prxs to
hyperoxidation could occur when they were exposed to the
same recycling pathway, we first lysed cells with detergent and
then assessed the sensitivity of the three Prxs to increasing con-
centrations ofH2O2 (Fig. 6A). Under these conditions, the cyto-
solic and mitochondrial reduction pathways would be diluted,
so to provide a source of reducing equivalents, we included
DTT (1 mM). Each of the Prxs was now sensitive to hyperoxi-
dation, with PrxIV as sensitive as PrxII.
To determine whether PrxIV would be as sensitive as the
other Prxswhen a source of reductant was present in the ER, we
took advantage of the fact that cells depleted of Ero1 do not
produceH2O2whenDTT is added (Fig. 2B). Hence, we can add
DTT to these cells, where it will act as a reductant, directly or
indirectly, for PrxIV without generating H2O2. When the
Ero1-depleted cells were incubatedwithH2O2 in the presence
of DTT, PrxIV became as sensitive to hyperoxidation as PrxII
(80% hyperoxidation at 100 M H2O2) (Fig. 6B). This result
demonstrates that ER-localized PrxIV is sensitive to hyperoxi-
dation when a reducing agent is included and explains why
PrxIV is sensitive to hyperoxidation in non-Ero1-depleted
cells whenDTT is present. In addition, it shows thatH2O2must
be able to permeate the ER membrane, proving that the lack of
hyperoxidation of PrxIV was not due to a lack of H2O2 in the
ER.
The DTT added to cells could reduce PrxIV directly or indi-
rectly via PDI. To determine whether DTT can directly accel-
erate the recycling of PrxIV and lead to hyperoxidation, we
incubated purified PrxIV with DTT and added increasing con-
centrations of H2O2 (Fig. 6C). The presence of DTT sensitized
PrxIV to hyperoxidation. However, this effect was more pro-
nounced when PDI was also included in the incubation. Taken
together with themore efficient hyperoxidation of PrxIV in the
presence of PDI and GSH (Fig. 5), we conclude that PDI or a
PDI family member is the primary reductant of PrxIV and that
maximal sensitivity can be achievedwhen eitherDTTorGSH is
present to reduce PDI. In the lumen of the ER, PrxIV is sensitive
to hyperoxidation only when PDI is efficiently reduced with
DTT. The resistance of PrxIV to hyperoxidation indicates that
an efficient mechanism to reduce PDI is absent from the ER.
FIGURE 5. Hyperoxidation of purified PrxIV in the presence of different reductants. Purified human PrxIV (2.8 M) was incubated in the presence of
different reductants and in the presence of increasing concentrations of H2O2 (0–10 mM) for 10 min. Samples were then separated by one-dimensional IEF.
Immunoblot analyses were developed using the rabbit polyclonal antibody to PrxIV (-prxIV). The oxidized forms of PrxIV were quantified, and the fraction
hyperoxidized at each concentration was calculated after subtracting the fraction hyperoxidized in the absence of added H2O2. Error bars represent the
mean S.D. from three independent experiments. trx, thioredoxin (2.8 M); trr, thioredoxin reductase (2.8 M).
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DISCUSSION
We developed a simple quantitative assay to address the
extent of hyperoxidation of members of the 2-Cys family of
Prxs. This assay, on the basis of separation by one-dimensional
IEF of the hyperoxidized from the unmodified form, can be
used to evaluate the efficiency of the thiol reduction pathways
in different intracellular organelles. The assay could also be
used to quantify hyperoxidation of Prxs during the cell cycle
(20) or to determine whether the oxidation status of Prxs
changes during circadian oscillations (21). Here we used the
assay to assess the sensitivity of Prxs in different cellular com-
partments to hyperoxidation following exposure to H2O2.
Although the pathway for reduction of PrxII and PrxIII is fairly
well characterized, the pathway for reduction of PrxIV was
unclear. It has been shown previously that the disulfide formed
in PrxI, II, and III following sulfenylation of the peroxidatic
cysteine is reduced by a thioredoxin, which itself is reduced by a
thioredoxin reductase present in the cytosol (PrxI and II) or
mitochondria (PrxIII), with the ultimate electron donor being
NADPH (6, 7). The fact that both Prx II and III were sensitive to
hyperoxidation in the presence of H2O2 confirms that the thio-
redoxin reduction pathway present in the cytosol or the mito-
chondria was not compromised in the presence of this oxidant.
The absence of hyperoxidation of PrxIV suggests that no equiv-
alent pathway exists in the ER lumen for the reduction of thio-
redoxin domain-containing proteins. The presence within the
FIGURE 6.Hyperoxidation of ER-localized PrxIV in the presence of a reducing pathway. A, a HT1080 cell lysate was incubated for 10 min in the presence
of DTT (1 mM) and increasing concentrations of H2O2, as indicated. Samples were then treated with N-ethylmaleimide and separated by one-dimensional IEF.
Prxs were detected as described in Fig. 3. Data presented are representative of three independent experiments. B, an Ero1-depleted cell line was incubated in
the presence of DTT (1mM) and increasing concentrations of H2O2 for 10min. Cells were treatedwithN-ethylmaleimide and lysed as described in Fig. 2 before
proteins were separated by one-dimensional IEF. The experiment was carried out in triplicate with similar results. C, purified PrxIV (2.8M) was incubatedwith
DTT (1 mM) with or without purified PDI (2.8 M). The assays were performed and quantified as described in Fig. 5.
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ER of several thioredoxin domain-containing proteins that make
up the PDI family allows the initial reduction of PrxIV (10). In the
absence of a thioredoxin reductase to reduce thePDI familymem-
ber, the disulfide within PrxIV will persist, thereby protecting the
peroxidatic cysteine from hyperoxidation.
The protection of Prx from hyperoxidation means that,
under normal physiological conditions, it is unlikely that PrxIV
becomes extensively inactivated by this mechanism. This is in
contrast to the other Prxs, which are regulated by hyperoxida-
tion to allow H2O2 to act as a signaling molecule and modify
proteins such as members of the protein tyrosine kinase family
(22). In contrast to the cytosolic enzymes that are recycled from
their hyperoxidized form by sulfiredoxin, hyperoxidized PrxIV
could not be recycled, suggesting that there is no ER-localized
sulfiredoxin.
Many studies regarding disulfide formation in the ER have
used DTT as an experimental tool to prevent disulfide forma-
tion during a short pulse and, upon its removal, have followed
the posttranslational formation of disulfides (23, 24). The
assumption has been that the effect of DTT over a short pulse
was to prevent disulfide formation because the reagent has no
effect on the secretion of non-disulfide-bonded proteins. The
demonstration that DTT also generates H2O2 in an Ero1-de-
pendent fashion and that this leads to the hyperoxidation and
inactivation of PrxIV should be taken into account when inter-
preting these previous studies. It should be noted that other
peroxidases, such as Gpx7 or 8, could contribute to the removal
of H2O2 under these conditions (25). However, like PrxIV, both
these enzymes require a disulfide exchange protein tomaintain
optimal activity. Although it is clear that the ER redox status
rapidly recovers from the added DTT by an Ero1-dependent
process (17, 26), the inactivation of PrxIV will have a conse-
quence for the metabolism of H2O2 for several hours following
the addition of DTT. Hence, the interpretation of the effect of
DTTaddition to cells on their ability to recover ER redox status,
to form disulfides, and tomount a stress response needs to take
into account the fact that H2O2 metabolism will be impaired
because of the inactivation of PrxIV.
Studies into the variation in the sensitivity of the 2-Cys per-
oxiredoxin family members to hyperoxidation has focused on
differences between the intrinsic ability of each enzyme to be
inactivated by H2O2 (5). Using purified protein, it has been
shown that PrxIII is more resistant to hyperoxidation than
PrxII because of subtle sequence differences within the C-ter-
minal region. In contrast to PrxIII, we show here that PrxIV is
resistant to hyperoxidation because of a lack of an efficient
recycling system in the ER. To demonstrate that the lack of
hyperoxidation was not due to an intrinsic resistance of this
enzyme, we showed that purified Prx IV was susceptible to
hyperoxidation in the presence of either a thioredoxin recycling
system or PDI with a reducing agent such as DTT or GSH. In
addition, ER-localized PrxIV also became sensitive to hyperoxi-
dation in the presence of DTT. These results confirm the
requirement for a PDI family member to directly reduce PrxIV
in the ER (10, 27) and show that the oxidized PDI can be effi-
ciently reduced in the presence of a reducing GSH buffer or
DTT. The requirement for a GSH buffer to maintain a reduc-
tive pathway in the ER has been suggested previously because
lowering the levels of intracellular GSH does not prevent disul-
fide formation but does lead to the persistence of non-native
disulfides in the secreted protein tissue-plasminogen activator
(28). The resistance of PrxIV to hyperoxidation in the ER indi-
cates that an efficient pathway for the reduction of GSSG is also
absent from the ER. Hence, a mechanism for GSSG/GSH
exchange between the ER and the cytosol most likely exists to
maintain a sufficiently reducing GSH:GSSG ratio to facilitate
the reduction of members of the PDI family and allow non-
native disulfide reduction.
Acknowledgments—We thank Gordon Lindsay and othermembers of
the Bulleid laboratory for critical reading of the manuscript.
REFERENCES
1. Wood, Z. A., Poole, L. B., Hantgan, R. R., and Karplus, P. A. (2002) Dimers
to doughnuts. Redox-sensitive oligomerization of 2-cysteine peroxiredox-
ins. Biochemistry 41, 5493–5504
2. Winterbourn, C. C. (2008) Reconciling the chemistry and biology of reac-
tive oxygen species. Nat. Chem. Biol. 4, 278–286
3. Hall, A., Karplus, P. A., and Poole, L. B. (2009) Typical 2-Cys peroxiredox-
ins. Structures, mechanisms and functions. FEBS J. 276, 2469–2477
4. Cao, Z., Tavender, T. J., Roszak, A. W., Cogdell, R. J., and Bulleid, N. J.
(2011) Crystal structure of reduced and of oxidized peroxiredoxin IV en-
zyme reveals a stable oxidized decamer and a non-disulfide-bonded inter-
mediate in the catalytic cycle. J. Biol. Chem. 286, 42257–42266
5. Haynes, A. C., Qian, J., Reisz, J. A., Furdui, C. M., and Lowther, W. T.
(2013) Molecular basis for the resistance of human mitochondrial 2-cys
peroxiredoxin 3 to hyperoxidation. J. Biol. Chem. 288, 29714–29723
6. Stacey, M.M., Vissers, M. C., andWinterbourn, C. C. (2012) Oxidation of
2-cys peroxiredoxins in human endothelial cells by hydrogen peroxide,
hypochlorous acid, and chloramines.Antioxid. Redox Signal. 17, 411–421
7. Yang, K. S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K.,
and Rhee, S. G. (2002) Inactivation of human peroxiredoxin I during ca-
talysis as the result of the oxidation of the catalytic site cysteine to cys-
teine-sulfinic acid. J. Biol. Chem. 277, 38029–38036
8. Biteau, B., Labarre, J., and Toledano, M. B. (2003) ATP-dependent reduc-
tion of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.Nature 425,
980–984
9. Tavender, T. J., and Bulleid, N. J. (2010) Peroxiredoxin IV protects cells
from oxidative stress by removing H2O2 produced during disulphide for-
mation. J. Cell Sci. 123, 2672–2679
10. Tavender, T. J., Springate, J. J., and Bulleid, N. J. (2010) Recycling of per-
oxiredoxin IV provides a novel pathway for disulphide formation in the
endoplasmic reticulum. EMBO J. 29, 4185–4197
11. Zito, E., Melo, E. P., Yang, Y., Wahlander, Å., Neubert, T. A., and Ron, D.
(2010) Oxidative protein folding by an endoplasmic reticulum-localized
peroxiredoxin.Mol. Cell. 40, 787–797
12. Wang, X., Wang, L., Wang, X., Sun, F., andWang, C. C. (2012) Structural
insights into the peroxidase activity and inactivation of human peroxire-
doxin 4. Biochem. J. 441, 113–118
13. Baker, K.M., Chakravarthi, S., Langton, K. P., Sheppard, A.M., Lu, H., and
Bulleid, N. J. (2008) Low reduction potential of Ero1 regulatory disulphi-
des ensures tight control of substrate oxidation. EMBO J. 27, 2988–2997
14. Woo, H. A., Kang, S. W., Kim, H. K., Yang, K. S., Chae, H. Z., and Rhee,
S. G. (2003) Reversible oxidation of the active site cysteine of peroxiredox-
ins to cysteine sulfinic acid. Immunoblot detection with antibodies spe-
cific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem.
278, 47361–47364
15. Wagner, E., Luche, S., Penna, L., Chevallet, M., Van Dorsselaer, A., Leize-
Wagner, E., and Rabilloud, T. (2002) A method for detection of overoxi-
dation of cysteines. Peroxiredoxins are oxidized in vivo at the active-site
cysteine during oxidative stress. Biochem. J. 366, 777–785
16. Chevallet, M.,Wagner, E., Luche, S., van Dorsselaer, A., Leize-Wagner, E.,
and Rabilloud, T. (2003) Regeneration of peroxiredoxins during recovery
Protection of Peroxiredoxin IV fromHyperoxidation
FEBRUARY 28, 2014•VOLUME 289•NUMBER 9 JOURNAL OF BIOLOGICAL CHEMISTRY 5497
 at G
lasgow
 U
niversity Library on June 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
after oxidative stress. Only some overoxidized peroxiredoxins can be re-
duced during recovery after oxidative stress. J. Biol. Chem. 278,
37146–37153
17. van Lith, M., Tiwari, S., Pediani, J., Milligan, G., and Bulleid, N. J. (2011)
Real-time monitoring of redox changes in the mammalian endoplasmic
reticulum. J. Cell Sci. 124, 2349–2356
18. Tavender, T. J., Sheppard, A.M., and Bulleid, N. J. (2008) Peroxiredoxin IV
is an endoplasmic reticulum-localized enzyme forming oligomeric com-
plexes in human cells. Biochem. J. 411, 191–199
19. Cox, A. G., Pearson, A. G., Pullar, J. M., Jönsson, T. J., Lowther, W. T.,
Winterbourn, C. C., and Hampton, M. B. (2009) Mitochondrial peroxire-
doxin 3 ismore resilient to hyperoxidation than cytoplasmic peroxiredox-
ins. Biochem. J. 421, 51–58
20. Phalen, T. J.,Weirather, K., Deming, P. B., Anathy, V., Howe, A. K., van der
Vliet, A., Jönsson, T. J., Poole, L. B., and Heintz, N. H. (2006) Oxidation
state governs structural transitions in peroxiredoxin II that correlate with
cell cycle arrest and recovery. J. Cell Biol. 175, 779–789
21. Edgar, R. S., Green, E. W., Zhao, Y., van Ooijen, G., Olmedo, M., Qin, X.,
Xu, Y., Pan, M., Valekunja, U. K., Feeney, K. A., Maywood, E. S., Hastings,
M. H., Baliga, N. S., Merrow, M., Millar, A. J., Johnson, C. H., Kyriacou,
C. P., O’Neill, J. S., and Reddy, A. B. (2012) Peroxiredoxins are conserved
markers of circadian rhythms. Nature 485, 459–464
22. Veal, E. A., Day, A. M., and Morgan, B. A. (2007) Hydrogen peroxide
sensing and signaling.Mol. Cell 26, 1–14
23. Lodish, H. F., and Kong, N. (1993) The secretory pathway is normal in
dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and
reversibly retained in the endoplasmic reticulum. J. Biol. Chem. 268,
20598–20605
24. Braakman, I., Helenius, J., and Helenius, A. (1992) Manipulating disulfide
bond formation and protein folding in the endoplasmic reticulum. EMBO
J. 11, 1717–1722
25. Nguyen, V. D., Saaranen, M. J., Karala, A. R., Lappi, A. K., Wang, L.,
Raykhel, I. B., Alanen, H. I., Salo, K. E., Wang, C. C., and Ruddock, L. W.
(2011) Two endoplasmic reticulum PDI peroxidases increase the effi-
ciency of the use of peroxide during disulfide bond formation. J. Mol. Biol.
406, 503–515
26. Appenzeller-Herzog, C., Riemer, J., Zito, E., Chin, K. T., Ron, D., Spiess,
M., and Ellgaard, L. (2010) Disulphide production by Ero1-PDI relay is
rapid and effectively regulated. EMBO J. 29, 3318–3329
27. Sato, Y., Kojima, R., Okumura, M., Hagiwara, M., Masui, S., Maegawa, K.,
Saiki, M., Horibe, T., Suzuki, M., and Inaba, K. (2013) Synergistic cooper-
ation of PDI family members in peroxiredoxin 4-driven oxidative protein
folding. Sci. Rep. 3, 2456
28. Chakravarthi, S., and Bulleid, N. J. (2004) Glutathione is required to reg-
ulate the formation of native disulfide bonds within proteins entering the
secretory pathway. J. Biol. Chem. 279, 39872–39879
Protection of Peroxiredoxin IV fromHyperoxidation
5498 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 9•FEBRUARY 28, 2014
 at G
lasgow
 U
niversity Library on June 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
